✦ LIBER ✦

DB3 COST-EFFECTIVENESS OF ROSIGLITAZONE-METFORMIN COMBINATION IN OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES IN GERMANY

✍ Scribed by A Shearer; A Bagust; O Schoeffski; U Reitberger; A Goertz; M Behrens

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antithrombotic Effects of Rosiglitazone-

✍ Dr. Giuseppe Derosa; Dr. Antonio V. Gaddi; Dr. Mario N. Piccinni; Dr. Leonardina 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Initial treatment with rosiglitazone/met

✍ J. Rosenstock; J. Rood; A. Cobitz; N. Biswas; H. Chou; A. Garber 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

PDB35 COST-EFFECTIVENESS ANALYSIS OF MET

✍ J Elgart; J Caporale; JJ Gagliardino; EC Aiello; M Waschbusch; L Jotimliansky 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PDB27 COST-EFFECTIVENESS ANALYSIS OF MET

✍ J. Elgart; J. Caporale; E.C. Aiello; M. Waschbusch; L. Jotimliansky; J.J. Gaglia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Acute myopathy in a type 2 diabetic pati

✍ M. Ledl; J. Hohenecker; C. Francesconi; I. Roots; M. F. Bauer; M. Roden 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 87 KB

Effect of Rosiglitazone, Metformin, and

✍ Zinman, Bernard; Haffner, Steven M.; Herman, William H.; Holman, Rury R.; Lachin 📂 Article 📅 2010 🏛 Endocrine Society 🌐 English ⚖ 132 KB